Nano Nuclear Energy Inc
NASDAQ:NNEIndustrial - Machinery
+$2.10 today
- Market cap
- $555.78M
- Beta
- 5.04
- P/E (TTM)
- -45.2
- EPS (TTM)
- -$0.61
Volume 1.63M
Average 2.53M
NNE Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Nano Nuclear Energy IncNASDAQ: NNE
Accounts Receivables · Q2 FY2026 · quarter ended Mar 2026
Accounts receivables outflow grows to $0
Q2 FY2026 accounts receivables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts receivables was -$336.38K.
Context
- Accounts receivables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$84.1K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (250K) USD
- Year-over-year change
- —
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | (250K) | — |
| FY2024 | 2024-09-30 | 0 | — |
| FY2023 | 2023-09-30 | 0 | — |
| FY2022 | 2022-09-30 | 0 | — |
Accounts Receivables vs competitors
How NNE compares with its peers on the latest reported figures
- NNE's LTM Mar 2026 accounts receivables of $336.38K is the 5th largest of the 8 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $45.81M | -974.0% | — | 1.3% | |
XEX-Energy, Inc. Class A Common Stock | FY2025 | $13.41M | — | — | 12.3% |
| LTM Jun 2026 | $1.24M | +116.8% | — | 11.7% | |
| LTM Sep 2026 | $1.15M | — | — | 37.6% | |
| LTM Mar 2026 | $336.38K | — | — | — | |
NKLRTerra Innovatum Global N.V. Ordinary shares | LTM Sep 2025 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
HDRNHadron Energy, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| — | — | — | — | — | |
NWCLnewcleo plc Ordinary Shares | — | — | — | — | — |
| Peer median (excluding NNE) | $0 | -428.6% | — | 11.7% | |
Competitors are the stored peer set for NNE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|
| Net Income | (1.03M) | (6.25M) | (10.15M) | (40.07M) |
| Depreciation & Amortization | 0 | 0 | 106.93K | 650.74K |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 705 | 2.82K | 320.26K | 18.82M |
| Change in Working Capital | 20.32K | (1.18K) | 473.73K | (237.34K) |
| Accounts Receivables | 0 | 0 | 0 | (250K) |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 87.23K | 571.47K | 553.12K |
| Other Working Capital | 20.32K | (88.41K) | (97.75K) | (540.46K) |
| Other Non-Cash Items | 389.3K | 2.38M | 786.5K | 1.21M |
| Operating Cash Flow | (621.5K) | (3.87M) | (8.46M) | (19.62M) |
| Capital Expenditures | 0 | 0 | (1.7M) | (17.52M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (2M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (9.08M) |
| Investing Cash Flow | 0 | 0 | (3.7M) | (17.52M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 2.75M | 8.77M | 34.95M | 227.28M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.75M | (75K) | (1.24M) | (15.38M) |
| Financing Cash Flow | 2.75M | 8.69M | 33.72M | 211.9M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.13M | 4.82M | 21.55M | 174.76M |
| Free Cash Flow | (621.5K) | (3.87M) | (10.16M) | (37.15M) |
Nano Nuclear Energy Inc
NASDAQ:NNE
Intrinsic Alpha fair value
Locked
Current Price
$10.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.